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Abstract
Using the main French health insurance company database over a
10-year period, the preventability of catheter-related infections
of patients who claimed compensation after prosecution was
reviewed by a panel expert. They occurred in 71 patients with
few co-morbidities or risk factors for nosocomial infection and
were mainly related to the use of a peripheral vascular catheter
(42 cases) and due to Staphylococcus aureus (51 cases). Forty-two
infections were considered to be preventable. Infections due to
peripheral venous catheters were significantly more often
preventable than those due to central ones (p < 0.05). We
conclude that catheter-related infections perceived by patients
and the justice system as not related to unforeseeable medical
complications are mainly peripheral catheter infections due to
S. aureus and might be an appropriate target for new preventive
strategies.
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Introduction
Intravenous peripheral (PVC) and central (CVC) catheters,
provide necessary vascular access, but put patients at risk of
infectious complications (local or systemic). Twenty-five million
PVCs and one million CVCs are estimated to be inserted each
year in France (1). The recently published French national
survey of hospital-associated infections described a prevalence
of 0.3% and below 0.1% for CVCs and PVCs, respectively (http://
www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses
/Maladies-infectieuses/2013/Enquete-nationale-de-prevalence-
des-infections-nosocomiales-et-des-traitements-anti-infect
ieux-en-etablissements-de-sante-France-mai-juin-2012). Noso-
comial bacteraemias were predominantly due to venous
catheters (33% CVC, 8.3% PVC). Incidence surveys aiming to
describe the epidemiology of hospital-onset bacteraemia
showed that the burden linked to these bacteraemias is
underestimated by point prevalence studies (2). In France, it
has been recently estimated that 12 400 patients died due to to
healthcare-associated bacteraemia (3).
The incidence of CVC-related infections and bacteraemia
was, respectively, 0.84 and 0.66/1000 days in intensive care
units (ICU) in the French network RAISIN (4). Assuming a
stronger incidence of 1.23/1000 days in France, the addi-
tional costs for the healthcare system related to central
catheter bloodstream infection (CRBSI) in ICUs was esti-
mated to be 100 to 130 million Euros a year (5). Most often
microorganisms responsible for CRBSI are coagulase-nega-
tive Staphylococcus (23% of cases) and Staphylococcus aureus
(17%).
None of these sources enable the evaluation of the
preventable part of intravascular catheter-related infections
(CRI). Another way to investigate this topic is to refer to
health insurance data. To obtain this information in France, we
asked SHAM, the main insurance company of French public
and private hospitals, to investigate the claimed cases of CRI.
The aim of the study was to describe vascular CRI claims to
SHAM, and to evaluate the preventability of these health-
care-associated infections.
Methods
Study population
This retrospective study was conducted using the database of
SHAM, after approval by the local ethics committee of the
University Hospital of Saint-Etienne, France. We searched the
database of SHAM, during the period 2000–2010, with the
following keywords: infections and catheters. A fellow,
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specializing in infectious diseases, studied the medical reports
of cases to confirm that each case was an intravascular CRI,
and to collect the data necessary to evaluate preventability.
Definitions used for CRI characterization were French ones
edited by the National Technical Committee of Nosocomial
Infection; they are in accordance with those described by Raad
et al. (6).
Data collection and statistical analysis
Collected data were characteristics of patients (age, sex,
co-morbidities, and risk factors for infection such as diabetes
mellitus, neutropenia, immunosuppressive agents, surgery and
blood transfusion) and type of catheters (peripheral catheter,
central venous catheter, arterial catheter, haemodialysis cath-
eter or totally implantable catheter). Statistical analysis was
performed using SPSS 20.0 (IBM, Chicago, IL, USA). We
compared the proportion of preventable infections related to
PVCs and CVCs using McNemar’s test.
Preventability judgement
A medical committee composed of two practitioners working
in ICU units and one working in an infection control unit
examined the selected cases to evaluate the preventability of
CRI. Adherence to guidelines for insertion, surveillance of
intravascular catheters, diagnosis of intravascular-related infec-
tions and characteristics of patients were taken into account to
determine the preventability of each case using a Lickert scale
(7). Preventability was defined as an unintended CRI that was
caused by medical management or a failure to meet the
reasonably expected standard of care. The probability of
preventability was graded using four categories: certainly or
probably preventable, moderate preventability, not prevent-
able, and undetermined probability. Preventable infections
were those with moderate and strong probability of prevent-
ability.
Results
Characteristics of cases
In France, more than sixty per cent of the hospital beds in
medicine, surgery and obstetrics are insured by SHAM (75%
public and 25% private). During the time period 2000–2010,
73 322 damages claims were made to SHAM. Five hundred and
eighty-three (0.8%) were classified with the keywords infec-
tions and catheters and only 75 (0.1%) of these cases were
effectively intravascular CRI. Four cases were excluded
because too much information was missing from the medical
files. Most of the cases (74%) occurred in patients admitted as
an emergency to the hospital. Thirty-four cases (48%) of CRI
occurred in the medical department, 21 (30%) in the surgical
department and only seven (10%) in the ICU. Characteristics
of the patients are depicted in Table 1. In 42 cases (60%),
infections were related to PVCs. Eight cases occurred in
paediatric patients (<15 years old), particularly in newborns.
Microorganisms responsible for infection and complications
associated with catheters
A microorganism was identified in 93% of cases of infection.
Staphylococcus aureus was the most frequent microorganism,
recovered in 51 cases (72%); coagulase-negative staphylococci
were responsible for three (4%) infections. In 10 (19%)
S. aureus infections, a resistance to methicillin was identified.
Other documented complications were: 13 patients with
osteitis or arthritis, four with spondylodiscitis, one with toe
amputation, two with infected arterial aneurysms, seven with
endocarditis, two with mycotic aneurysms, one with pulmo-
nary embolism, two with venous thrombophlebitis, one with
infected haematoma and 14 with thrombosis of catheters. Ten
osteo-articular infections and five cases of endocarditis were
related to PVC infection.
Outcomes
In 48 cases (68%), CRI induced sepsis: two (3%) were severe
and 15 (21%) resulted in septic shock (five children). Surgery
or an ICU stay was necessary in 23 (34%) and 22 (32%) cases,
respectively. Death was attributable to CRI in eight cases
(11%). When analyzing only the infections related to PVCs (42
cases), septic shock was observed in eight cases (19%). Surgery
TABLE 1. Characteristics of the patients who developed
intravascular catheter-related infections (mean and SD for
continuous variables, number and percentage for categorical
variables)
Characteristics (n, %)
Age 47  22 years
Sex ratio (M/F) 2.1/1
Charlson Score at admission 1 (1.9)
Presence of risk factors for infectiona 29 patients (41)
Category on hospital admission
Medicine 34 (48)
Surgery 21 (30)
Intensive care unit 7 (10)
Others (rehabilitation, obstetrics, psychiatry. . .) 9 (13)
Type of catheter
Peripheral venous catheter 42 (59)
Central venous catheter 26 (37)
Otherb 3 (4)
Bacteraemia 49 (69)
Peripheral venous catheter 31 (74)
Central venous catheter 18 (70)
aSeptic shock, multiple organ failure, polytrauma, immunocompromised patient,
cancer, major surgery, diabetes requiring insulin therapy, low birth weight
(<1500 g), parenteral nutrition, prosthesis, blood transfusions.
bUmbilical catheters.
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and an ICU stay were necessary in 12 (29%) and nine (21%)
cases, respectively. The mean cost for SHAM of an intravas-
cular CRI, using the data on 59 damages claims, for which the
procedure was completed by the study date, was evaluated at
18 153 € (39 956, 0–231 700).
Preventability
Forty-two infections (62%) were considered to be preventable
by the expert committee: 31 (74%) for PVCs and 11 (38%) for
CVCs. Identified contributing factors that could have influ-
enced the occurrence of CRI are displayed in Table 2.
Infections due to PVCs were significantly more often prevent-
able than those due to CVCs (p < 0.05). According to
guidelines (1), catheters should have been removed or
replaced before the occurrence of the infection in 22 (52%)
cases of PVC infection and in eight (28%) cases of CVC
infection. Other contributing factors reported in the prevent-
able infections were errors in hand hygiene, aseptic technique
and skin preparation and absence of daily evaluation of the
catheter insertion site. Overall, the money potentially saved by
preventive measures was calculated to be 782 752 euros
(57.5% of costs paid by SHAM).
Discussion
To our knowledge, this is the first published study describing
vascular catheter-related infection using the database of an
insurance company. Additionally, this study brings new
insights into the prevention of CRI. First, these infections
occurred in patients with few co-morbidities or risk factors
for nosocomial infections. Second, the most common
microorganism isolated from these infections was Staphylo-
coccus aureus, which is most of time susceptible to methicillin
(81%). Third, most of the infections in claims made to SHAM
were preventable, particularly in the case of peripheral
catheters. These results contrast with the observations in
the French survey of prevalence of nosocomial infections,
and the survey of the ICUs from RAISIN where methicillin
resistance is frequent: 38.1% and 35%, respectively (1,7). We
observed that CRIs are a minor cause of damage claims
made to SHAM (11 423 claims overall in 2012, of which
7.2% were related to infection). In this database, the young
age of patients, the absence of co-morbidity at admission and
the small proportion of infections occurring in ICUs
probably explained why patients made claims. It can also
be hypothesized that only the patients who suffered the
most severe infections have filed claims, which clearly
underestimates the number of catheter-related infections.
Additionally, a high number of complications related to PVC
infection were observed, in accordance with a recent
study (8) underlying the substantial burden due to these
infections.
One study already described a greater proportion of CRIs
due to Staphylococcus aureus in peripheral venous catheter
infections than in central venous catheter infections (9).
Accordingly, the greater proportion of PVC infections in our
study may, in part, explain the increased frequency of
S. aureus infections. In the literature, the incidence of CRI
associated with PVCs is low (0–0.2% bacteraemia), but there
is considerable morbidity because of the frequency with
which such catheters are used (10). Although this study is
not representative of the epidemiology of vascular CRI (11),
these results highlight that peripheral venous catheters could
be a cause of severe hospital-associated infections. Catheters
should have been removed or replaced before the occur-
rence of the infection in 71% of cases. A recent study showed
that no more complications were observed when PVCs were
removed as clinically indicated compared with routine replace-
ment (12) but not all the catheter tips were cultured. French
guidelines state that, in adults, it is recommended that PVCs
should not be left in place for longer than 96 h, except in
patients with a limited venous capital, provided the insertion
site is carefully monitored and there are no complications
(http://www.sf2 h.net/SF2H_english/SF2H_surveillance-and-pr
evention-guidelines-2010.pdf). We believe that efforts must be
made to not underestimate the infectious risk linked to PVCs
and better prevent this type of infection.
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TABLE 2. Identified factors contributing to the 42 prevent-
able CRIs (in two cases, two contributing factors were
identified)
Factors contributing to CRI
N (% of
overall CRIs)
Defects in hand hygiene and aseptic
technique
3 (4.2)
Defects in skin disinfection 6 (8.4)
Catheters replaced after 72–96 h 13 (18.3)
Catheters not removed despite local
signs suggesting CRI
12 (16.9)
Catheter not replaced when adherence
to aseptic method was not ensured
1 (1.4)
No indicated catheter use 4 (5.6)
Defects in medical care after first local
clinical signs of CRI
5 (7.1)
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